Publicaciones en colaboración con investigadores/as de Medical University of Vienna (19)

2024

  1. Prognostic Implications of Residual Tricuspid Regurgitation Grading After Transcatheter Tricuspid Valve Repair

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 12, pp. 1485-1495

  2. TRI-SCORE and benefit of intervention in patients with severe tricuspid regurgitation

    European heart journal, Vol. 45, Núm. 8, pp. 586-597

  3. Tricuspid valve disease and cardiac implantable electronic devices

    European Heart Journal, Vol. 45, Núm. 5, pp. 346-365

2022

  1. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study

    JACC: Cardiovascular Interventions, Vol. 15, Núm. 13, pp. 1366-1377

  2. Tricuspid regurgitation: recent advances in understanding pathophysiology, severity grading and outcome

    European heart journal. Cardiovascular Imaging, Vol. 23, Núm. 7, pp. 913-929

2021

  1. Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

    Internal and Emergency Medicine, Vol. 16, Núm. 3, pp. 591-599

  2. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR

    New England Journal of Medicine, Vol. 385, Núm. 23, pp. 2150-2160

  3. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    EuroIntervention, Vol. 17, Núm. 5, pp. E367-E375

  4. European position paper on the management of patients with patent foramen ovale. Part II - Decompression sickness, migraine, arterial deoxygenation syndromes and select high-risk clinical conditions

    European Heart Journal, Vol. 42, Núm. 16, pp. 1545-1553

2020

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS)

    European Heart Journal, Vol. 41, Núm. 4, pp. 543-603

  2. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)

    European Journal of Heart Failure, Vol. 22, Núm. 9, pp. 1504-1524

2019

  1. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)

    European Respiratory Journal, Vol. 54, Núm. 3

  2. European position paper on the management of patients with patent foramen ovale. General approach and left circulation thromboembolism

    European Heart Journal, Vol. 40, Núm. 38, pp. 3182-3195

2016

  1. Recommendations for the imaging assessment of prosthetic heart valves: A report from the European Association of Cardiovascular Imaging endorsed by the Chinese Society of Echocardiography, the Inter-American Society of Echocardiography, and the Brazilian Department of Cardiovascular Imaging

    European Heart Journal Cardiovascular Imaging, Vol. 17, Núm. 6, pp. 589-590

2014

  1. Appropriateness criteria for cardiovascular imaging use in clinical practice: A position statement of the ESC/EACVI taskforce

    European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 5, pp. 477-482

  2. Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging: An executive summary

    European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 11, pp. 1188-1193

  3. Updated standards and processes for accreditation of echocardiographic laboratories from the European Association of Cardiovascular Imaging

    European Heart Journal Cardiovascular Imaging, Vol. 15, Núm. 7, pp. 717-727

2013

  1. Normal Reference Ranges for Echocardiography: Rationale, study design, and methodology (NORRE Study)

    European Heart Journal Cardiovascular Imaging, Vol. 14, Núm. 4, pp. 303-308

  2. Vandetanib in advanced medullary thyroid cancer: Review of adverse event management strategies

    Advances in Therapy, Vol. 30, Núm. 11, pp. 945-966